Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The ras oncogene encodes the p21 protein, implicated in cell growth and differentiation.
• Aberrant ras p21 expression is observed in various cancers, including breast cancer.
• Understanding p21's role in breast cancer progression is crucial for identifying new therapeutic targets.

Purpose of the Study:

• To investigate the association between ras p21 expression and axillary lymph node status in primary breast carcinomas.
• To explore the correlation of p21 expression with tumor size, patient age, and estrogen receptor status.

Main Methods:

• Immunohistochemical assay was used to quantify ras p21 antigen staining in primary breast tumor tissues.
• Patients were categorized into lymph node-positive (LN+) and lymph node-negative (LNO) groups.
• Statistical analysis compared p21 expression levels between the two groups and correlated findings with clinical parameters.

Main Results:

• Significantly higher intensity and percentage of neoplastic cells showed ras p21 staining in LN+ primary tumors compared to LNO tumors.
• Ras p21 expression correlated positively with primary tumor size.
• p21 antigen expression was consistent in primary tumors and regional lymph node metastases.

Conclusions:

• Enhanced ras p21 expression in primary breast cancers is associated with lymph node metastasis.
• Ras p21 may serve as a determinant of breast cancer's malignant potential and a novel tumor marker.
• These findings highlight the clinical relevance of ras p21 in predicting breast cancer progression.